ArticleOncotarget2014

A novel drug discovery strategy: mechanistic investigation of an enantiomeric antitumor agent targeting dual p53 and NF-κB pathways.

Chunlin Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.